NEW YORK—Biopharmaceutical company Transition Therapeutics Inc. said Thursday it named Chief Financial Officer Elie Farah to the additional role of president.
The company also named Nicole Rusaw-George the company's vice president of finance.
Farah joined the company in 2005 as CFO and vice president of corporate development. Rusaw-George also started at the company in 2005 and was previously the director of finance.
© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
